Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine

Gastric Cancer

Volumn 11, Issue 4, 2008, Pages 201-205

  Ono, Makiko ^a   Shirao, Kuniaki ^b   Takashima, Atsuo ^a   Morizane, Chigusa ^a   Okita, Natsuko ^a   Takahari, Daisuke ^a   Hirashima, Yoshinori ^a   Eguchi Nakajima, Takako ^a   Kato, Ken ^a   Hamaguchi, Tetsuya ^a   Yamada, Yasuhide ^a   Shimada, Yasuhiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; Chemotherapy; Cisplatin; Irinotecan; Small intestine

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; FLUOROURACIL; FUROSEMIDE; GLUCOSE; IRINOTECAN; MITOMYCIN; SODIUM CHLORIDE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER SURVIVAL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIARRHEA; DRUG FATALITY; ERYTHEMA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HEARING DISORDER; HUMAN; LEUKOPENIA; LIVER DYSFUNCTION; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; NEUTROPENIA; PRIORITY JOURNAL; SIDE EFFECT; SMALL INTESTINE ADENOCARCINOMA; SMALL INTESTINE CANCER; TASTE DISORDER; TREATMENT FAILURE; TREATMENT RESPONSE; VOMITING;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CISPLATIN; DUODENAL NEOPLASMS; FEMALE; HUMANS; ILEAL NEOPLASMS; INTESTINAL NEOPLASMS; JEJUNAL NEOPLASMS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM METASTASIS;

EID: 58149467922     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-008-0484-5     Document Type: Article

References (14)

1. S.W. Ashley S.A. Wells Jr. 1988 Tumors of the small intestine Semin Oncol 15 116 128
2. A.I. Neugut M.R. Marvin V.A. Rella J.A. Chabot 1997 An overview of adenocarcinoma of the small intestine Oncology 21 529 536
3. T. Delaunoit F. Neczyporenko P.J. Limburg C. Erlichman 2004 Small bowel adenocarcinoma: a rare but aggressive disease Clin Colorectal Cancer 4 241 248
4. P.H. Green B. Jabri 2002 Celiac disease and other precursors to smallbowel malignancy Gastroenterol Clin North Am 31 625 639
5. M.K. Gibson C.A. Holcroft L.K. Kvols D. Haller 2005 Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma Oncologist 10 132 137
6. C. Locher D. Malka V. Boige P. Lebray D. Elias P. Lasser 2005 Combination chemotherapy in advanced small bowel adenocarcinoma Oncology 69 290 294
7. A. Polyzos G. Kouraklis A. Giannopoulos J. Bramis J.K. Delladetsima P.P. Sfikakis 2003 Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients J Chemother 15 503 506
8. D. Jigyasu A.Y. Bedikian J.R. Stroehlein 1984 Chemotherapy for primary adenocarcinoma of the small bowel Cancer 53 23 25
9. C. Crawley P. Ross A. Norman A. Hill D. Cunningham 1998 The Royal Marsden experience of small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil Br J Cancer 78 508 510
10. K. Shirao Y. Shimada H. Kondo D. Saito T. Yamao H. Ono 1997 Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer J Clin Oncol 15 921 927
11. N. Boku A. Ohtsu Y. Shimada K. Shirao S. Seki H. Saito 1999 Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer J Clin Oncol 17 319 323
12. N. Boku S. Yamamoto K. Shirao T. Doi A. Sawaki H. Koizumi 2007 Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912) J Clin Oncol 25 18S LBA4513
13. P.N. Fishman G.R. Pond M.J. Moore A. Oza R.L. Burkes L.L. Siu 2006 Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases Am J Clin Oncol 29 225 231
14. C. Erlichman R.M. Goldberg J.A. Sloan J.M. Reid A.A. Adjei P.J. Atherton 2002 Phase I study of the combination of CPT-11/5FU/leucovorin/oxaliplatin Proc Am Soc Clin Oncol 21 107a